NASDAQ: DRUG - Bright Minds Biosciences Inc.

六个月盈利: +3 627.1%
股息率: 0.00%
部门: Healthcare

促销时间表 Bright Minds Biosciences Inc.

先进的时间表 简单图表
Financial Markets by TradingView

关于公司 Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc., a biotechnology company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists includes 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry. The company has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin. Bright Minds Biosciences Inc.

更多详情
was founded in 2017 and is headquartered in New York, New York.
添加到比较列表
添加到观察列表
添加到投资组合
添加价格通知

IPO date 2021-03-22
ISIN CA10919W1086
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета cad
Сайт https://brightmindsbio.com
Цена ао 1.09
每日价格变化: -0.7466% (40.18)
每周价格变化: +3.18% (38.65)
每月价格变化: +1.79% (39.18)
3个月内价格变化: +3 168.85% (1.22)
六个月内的价格变化: +3 627.1% (1.07)
每年价格变化: +2 688.81% (1.43)
3年内价格变化: +1 090.45% (3.35)
5年内价格变化: 0% (39.88)
10年价格变化: 0% (39.88)
年初以来价格变化: +4.64% (38.11)
所有参数

低估

姓名 意义 年级
P/S 0 0
P/BV 1.33 9
P/E 0 0
EV/EBITDA -0.2851 0
全部的: 3.63

效率

姓名 意义 年级
ROA, % -107.17 0
ROE, % -111.73 0
全部的: 0

股息

姓名 意义 年级
Div yield, % 0 0
DSI 0 0
全部的: 0

责任

姓名 意义 年级
Debt/EBITDA -0.01 10
全部的: 9.8

成长冲动

姓名 意义 年级
盈利能力 Revenue, % 0 0
盈利能力 Ebitda, % 9148 10
盈利能力 EPS, % 4265.42 10
全部的: 8
更多详情

机构 体积 分享, %
AdvisorShares Investments, LLC 188119 4.24
HRT Financial LP 16845 0.38
Renaissance Technologies, LLC 11996 0.27
Virtu Financial LLC 10399 0.23
UBS Group AG 622 0.01
Royal Bank of Canada 278 0.01
Aspire Private Capital, LLC 100 0
Blackrock Inc. 1 0



导师 职称 支付 出生年份
Mr. Ian McDonald Co-Founder, CEO, President & Director N/A 1989 (36 年)
Mr. Ryan E. S. K. Cheung B.Com., CA, CPA Chief Financial Officer 87.89k 1978 (47 年)
Dr. Jan Torleif Pedersen M.Sc., Ph.D. Chief Science Officer & Director 178.37k 1965 (60 年)
Dr. Emer Leahy M.B.A., Ph.D. Consultant N/A 1967 (58 年)
Dr. Mark A. Smith M.D., Ph.D. Chief Medical Officer 239.88k 1955 (70 年)
Mr. Alex Vasilkevich COO & VP of Corporate Development

地址: United States, New York, 19 Vestry Street - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://brightmindsbio.com